Global Head of Patient Safety Operations

Who We Are

A Roche, você pode-se apresentar como você mesmo, abraçado pelas qualidades únicas que traz. Nossa cultura incentiva a expressão pessoal, o diálogo aberto e as conexões genuínas, onde você é valorizado e respeitado por quem você é, e permitindo que você prospere tanto pessoal como profissionalmente. É assim que pretendemos prevenir, deter e curar doenças e garantir que todos tenham acesso aos cuidados de saúde hoje e nas gerações futuras.

Junte-se à Roche, onde cada voz é importante.

The Product Development Safety (PDS) organisation delivers patient-centric solutions that build trust and create value for society, leading smarter safety design and decision-making activities throughout the lifecycle. PDS sustains Pharmacovigilance (PV) system compliance and quality, to foster trust and drive efficiency while innovating and improving the capabilities that address the evolving priorities of our enterprise.

The Global Head of Patient Safety Operations is a pivotal role for the organisation and is leading the building and implementation of the Patient Safety Operations strategy, driving industry leading global and regional operational excellence. You will be accountable for the execution of key safety processes that are essential to meet regulatory requirements, aid scientific analysis and advance the delivery of patient centric safety.

In this role you drive and strategically lead priorities for Patient Safety Operations across multiple locations supporting the overall PDS Strategy. You lead and empower the Patient Safety Operations team and ensure efficient, cost effective, high quality and compliant delivery of operational activities, establishing beneficial relationships with vendors supporting the Patient Safety Operations deliverables. As the Global Head of Patient Safety Operations you will be a member of PDS’ leadership team, ensuring the effectiveness of PDS on a day-to-day basis and for impactful long term strategic programs.

Delivery of above-country safety operational activities, ensuring consistent execution, globally and across regional hubs, including (but not limited to):
Leading Patient Safety Operations Teams responsible for Individual Case Safety reports (ICSR) and medical device safety report collection, processing, and reporting, including associated quality and training activities

Collaborating closely with stakeholders including International Patient Safety (IPS) Global Head and Regional Heads, Affiliate Safety Leaders to ensure operational requirements, and identification of further opportunities and innovation

Collaborating closely with Roche technology organisations and technology vendors to maximize technological performance while driving cost optimization

Working closely with the Global Process Owners and Business Process Owners to ensure up-to-date processes and procedures

Providing vigilance expertise on operational processes to stakeholders including clinical, development and marketing teams.

Consulting on safety data collection obligations from all sources of Roche Pharma products and modalities, classification and assessment of global digital activities, review of eCRFs for clinical trials, PV approval for global Market Research and Patient Support Programs

Negotiating, implementing and establishing safety agreements (eg. PVAs, SDEAs, Safety Management Plans etc) with partners

Leading and guiding Regulatory Reporting Services Team accountable for contributing information to the global Safety Regulatory Document Preparation process

PDS performance standards within Patient Safety Operations moving towards quality and compliance as a competitive advantage:
Ensuring tasks are performed according to international regulatory requirements, internal standards and in alignment with PDS strategies

Achieving defined performance metrics for patient safety operations processes

Ensuring Patient Safety Operations function is inspection ready, assisting PDS and Pharma Development (PD) Quality during inspections and audits

Partnering with PD and Pharma stakeholders to set clear data…